Citation Impact
Citing Papers
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
2004 StandoutScience
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients.
1989
Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia
2010
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
2002
AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
1996 Standout
The Third Intergroup Rhabdomyosarcoma Study.
1995 Standout
Clinical translation of angiogenesis inhibitors
2002 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Molecular classification of T-cell lymphomas
2009
Classification of primary cutaneous T‐cell lymphomas
1994
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor
1999 StandoutNobel
Acute lymphoblastic leukaemia
2013
Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene
1993
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study
2002 Standout
Network medicine: a network-based approach to human disease
2010 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Cancer stem cells revisited
2017 Standout
The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development
1994 StandoutNobel
Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling
2000 StandoutNobel
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Hodgkin's Disease, Lymphomatoid Papulosis, and Cutaneous T-Cell Lymphoma Derived from a Common T-Cell Clone
1992
Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma.
1991
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis.A European multicenter study of 47 patients
1993
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
2009
Downregulation of nitrovasodilator‐induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin‐1β
1996 StandoutNobel
A Novel B Cell Line Established from Ki‐1‐positive Diffuse Large Cell Lymphoma
1988
CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group.
1995
Treatment of Acute Lymphoblastic Leukemia
2006
Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling
1995 Standout
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Angiogenesis in B Cell Lymphoproliferative Diseases. Biological and Clinical Studies
1995
A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (‘Ki‐1 lymphoma')
1989
Clinical significance of early T‐cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children’s Cancer Study Group Study L99‐15
2011
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
The cancer stem cell: premises, promises and challenges
2011 Standout
Childhood Leukemias
1995
The Role of CTLA‐4 in the Regulation and Initiation of T‐Cell Responses
1996 StandoutNobel
The Management of Neoplastic Disorders of Haematopoeisis in Children with Down's Syndrome
2000
Clinical and biological importance of cytogenetic abnormalities in childhood and adult acute lymphoblastic leukemia
2004
Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based Lymphomas
1995 Standout
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
MicroRNA expression profiles classify human cancers
2005 StandoutNatureNobel
Down's syndrome
2003 Standout
Points of control in inflammation
2002 StandoutNature
Tumor-Cell DNA Content Predicts Outcome in Children and Adolescents With Clinical Group III Embryonal Rhabdomyosarcoma
1994
Stem cell factor (SCF), a novel hematopoietic growth factor and ligand for c-kit tyrosine kinase receptor, maps on human chromosome 12 between 12q14.3 and 12qter
1991
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
1995 Standout
Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells
1996 StandoutNobel
Cutaneous manifestations of postthymic T cell malignancies: Description of five clinicopathologic subtypes
1990
MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities
1997
Childhood acute lymphoblastic leukemia
2002
Expression of Cytochrome bsss on B Cell- and CD 30 Positive-lymphomas
1993
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Using GOstats to test gene lists for GO term association
2006 Standout
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Seed Germination and Dormancy.
1997 Standout
Cutting Edge: Ectopic Expression of CD40 Ligand on B Cells Induces Lupus-Like Autoimmune Disease
2002 StandoutNobel
A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T- cell lymphoma mimicking malignant histiocytosis
1989
REGULATION OF IMMUNE RESPONSES BY TGF-β
1998 Standout
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86
1994
Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis.
1988
Metabolic Flux Responses to Pyruvate Kinase Knockout in Escherichia coli
2002 StandoutNobel
Twelve cases of Ki-1 positive anaplastic large cell lymphoma of skin.
1991
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen.
1990 StandoutNobel
Cellular energy utilization and molecular origin of standard metabolic rate in mammals
1997 Standout
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
1997 Standout
Neutralizing antibodies against transforming growth factor beta potentiate the proliferation of Ki-1 positive lymphoma cells. Further evidence for negative autocrine regulation by transforming growth factor beta.
1992
Expression Levels of B Cell Surface Immunoglobulin Regulate Efficiency of Allelic Exclusion and Size of Autoreactive B-1 Cell Compartment
1999 StandoutNobel
Quantitative analysis of intermediary metabolism in hepatocytes incubated in the presence and absence of glucagon with a substrate mixture containing glucose, ribose, fructose, alanine and acetate
1985
Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger
2008 StandoutNobel
Cancer treatment and survivorship statistics, 2016
2016 Standout
Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762)
1992
Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics.
1989
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
2001 Standout
Improved scoring of functional groups from gene expression data by decorrelating GO graph structure
2006 Standout
Nitric oxide modulation of human leukemia cell differentiation and gene expression
1992
CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy
1995
Molecular Genetics of Acute Lymphoblastic Leukemia
2005
Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders
1993
A tumor profile in Down syndrome
1998
Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13.
1992
Loss of receptors for transforming growth factor beta in human T-cell malignancies.
1994
Current status of cytogenetic research in childhood acute lymphoblastic leukemia
1993
Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891.
1998
Quantification of carbon fluxes through the tricarboxylic acid cycle in early germinating lettuce embryos.
1988
Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival
2003
Establishment of a human cell line (mono mac 6) with characteristics of mature monocytes
1988
Physiological and Nutritional Regulation of Enzymes of Triacylglycerol Synthesis
2000
Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
1994 StandoutScience
Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)
1997
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Flow cytometric immunophenotyping for hematologic neoplasms
2008
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
The use of 6-labeled glucose to assess futile cycling in Escherichia coli.
1980
Incidence and Clinical Relevance of TEL/AML1 Fusion Genes in Children With Acute Lymphoblastic Leukemia Enrolled in the German and Italian Multicenter Therapy Trials
1997
Leukemic cell growth in SCID mice as a predictor of relapse in high- risk B-lineage acute lymphoblastic leukemia
1995
Works of M Borowitz being referenced
Correlation of monoclonal antibody phenotyping and cellular DNA content in non-Hodgkin's lymphoma. The southeastern cancer study group experience
1987
High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative
2005
2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: Medical indications
2007
Optimal number of reagents required to evaluate hematolymphoid neoplasias: Results of an international consensus meeting
2001
Immunophenotypes and karyotypes of leukemic cells in children with Down syndrome and acute lymphoblastic leukemia.
1993
Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study.
1992
Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study.
1990
Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study
1999
Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
1998
Triacylglycerol turnover in Tetrahymena pyriformis relation to phospholipid synthesis
1976
Cooperative effects of gamma interferon and 1-alpha,25-dihydroxyvitamin D3 in inducing differentiation of human promyelocytic leukemia (HL-60) cells.
1986
Quantitative analysis of the change of metabolite fluxes along the pentose phosphate and glycolytic pathways in Tetrahymena in response to carbohydrates.
1977
tdic(9;12): a nonrandom chromosome abnormality in childhood B-cell precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study
1987
Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy
1986
Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study
1990
Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study
1990
Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study
1990